Deletion of chromosome 13q14.3 occurs in multiple myeloma, non-Hodgkins lymphoma, chronic lymphocytic leukemia, myeloproliferative disorders, myelodysplastic syndrome, and acute nonlymphocytic leukemia. The D13S319 Fluorescence In Situ Hybridization (FISH) probe is useful in detecting deletions in a higher percentage of cells than by routine cytogenetic studies. The probe can be used to evaluate complex karyotypes for loss of this critical gene region. 

Empire Genomics has developed a custom D13S319 probe which can be used to detect/confirm a rearrangement of the D13S319 gene. The probe comes labeled in orange, and generally ships within 24 hours. You can choose to customize the probe to meet your needs, which will ship right after production of the probe is complete (approximately 1 week).

Probe Details

Gene:	D13S319 (Orange 5-TAMRA dUTP)
Loci:	13q14
Test Kits:	20

 

The leading supplier of molecular diagnostics for customization and production of FISH probes, aGCH assays and upcoming new technologies to be used by Reference labs, Academic labs, Pharma, CRO’s
and Pharma /Biotech companies around the world.

Our companion Diagnostics will allow you to :
-Validate Bio-markers (signature identification and resistance).
-Identify and qualify the aberration at the Chromosomal level of specific population.
-Follow up the result of therapeutic treatment (monitoring, compound profiling, drug response, patient stratification and safety)
-Compare with the result of your current technology.
-Be translated into the initial phase of your diagnostics development toward new FDA filings (pre-clinical through clinical trial development).